• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种分析固体分散体溶解机制的新方法。

A Novel Approach for Analyzing the Dissolution Mechanism of Solid Dispersions.

作者信息

Ji Yuanhui, Paus Raphael, Prudic Anke, Lübbert Christian, Sadowski Gabriele

机构信息

TU Dortmund, Department of Biochemical and Chemical Engineering, Laboratory of Thermodynamics, Emil-Figge-Str. 70, 44227, Dortmund, Germany,

出版信息

Pharm Res. 2015 Aug;32(8):2559-78. doi: 10.1007/s11095-015-1644-z. Epub 2015 Feb 27.

DOI:10.1007/s11095-015-1644-z
PMID:25715696
Abstract

PURPOSE

To analyze the dissolution mechanism of solid dispersions of poorly water-soluble active pharmaceutical ingredients (APIs), to predict the dissolution profiles of the APIs and to find appropriate ways to improve their dissolution rate.

METHODS

The dissolution profiles of indomethacin and naproxen from solid dispersions in PVP K25 were measured in vitro using a rotating-disk system (USP II). A chemical-potential-gradient model combined with the thermodynamic model PC-SAFT was developed to investigate the dissolution mechanism of indomethacin and naproxen from their solid dispersions at different conditions and to predict the dissolution profiles of these APIs.

RESULTS

The results show that the dissolution of the investigated solid dispersions is controlled by dissolution of both, API and PVP K25 as they codissolve according to the initial API loading. Moreover, the dissolution of indomethacin and naproxen was improved by decreasing the API loading in polymer (leading to amorphous solid dispersions) and increasing stirring speed, temperature and pH of the dissolution medium. The dissolution of indomethacin and naproxen from their amorphous solid dispersions is mainly controlled by the surface reaction, which implies that indomethacin and naproxen dissolution can be effectively improved by formulation design and by improving their solvation performance.

CONCLUSIONS

The chemical-potential-gradient model combined with PC-SAFT can be used to analyze the dissolution mechanism of solid dispersions and to describe and predict the dissolution profiles of API as function of stirring speed, temperature and pH value of the medium. This work helps to find appropriate ways to improve the dissolution rate of poorly-soluble APIs.

摘要

目的

分析难溶性活性药物成分(API)固体分散体的溶出机制,预测API的溶出曲线,并找到提高其溶出速率的合适方法。

方法

采用旋转圆盘系统(USP II)在体外测定吲哚美辛和萘普生在PVP K25固体分散体中的溶出曲线。建立了结合热力学模型PC-SAFT的化学势梯度模型,以研究吲哚美辛和萘普生在不同条件下从其固体分散体中的溶出机制,并预测这些API的溶出曲线。

结果

结果表明,所研究的固体分散体的溶出受API和PVP K25两者的溶出控制,因为它们根据初始API载量共同溶解。此外,通过降低聚合物中的API载量(形成无定形固体分散体)以及提高搅拌速度、温度和溶出介质的pH值,可改善吲哚美辛和萘普生的溶出。吲哚美辛和萘普生从其无定形固体分散体中的溶出主要受表面反应控制,这意味着通过制剂设计和改善其溶剂化性能可有效提高吲哚美辛和萘普生的溶出。

结论

结合PC-SAFT的化学势梯度模型可用于分析固体分散体的溶出机制,并描述和预测API的溶出曲线与搅拌速度、温度和介质pH值的关系。这项工作有助于找到提高难溶性API溶出速率的合适方法。

相似文献

1
A Novel Approach for Analyzing the Dissolution Mechanism of Solid Dispersions.一种分析固体分散体溶解机制的新方法。
Pharm Res. 2015 Aug;32(8):2559-78. doi: 10.1007/s11095-015-1644-z. Epub 2015 Feb 27.
2
Influence of excipients on solubility and dissolution of pharmaceuticals.辅料对药物溶解度和溶出度的影响。
Int J Pharm. 2015 May 15;485(1-2):277-87. doi: 10.1016/j.ijpharm.2015.03.004. Epub 2015 Mar 5.
3
Influence of copolymer composition on the phase behavior of solid dispersions.共聚物组成对固体分散体相行为的影响。
Mol Pharm. 2014 Nov 3;11(11):4189-98. doi: 10.1021/mp500412d. Epub 2014 Oct 21.
4
Long-Term Physical Stability of PVP- and PVPVA-Amorphous Solid Dispersions.聚乙烯吡咯烷酮和聚乙烯吡咯烷酮-醋酸乙烯酯无定形固体分散体的长期物理稳定性
Mol Pharm. 2017 Jan 3;14(1):157-171. doi: 10.1021/acs.molpharmaceut.6b00763. Epub 2016 Dec 7.
5
A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.喷雾干燥和粉碎在磺胺噻唑/聚乙烯吡咯烷酮和磺胺嘧啶/聚乙烯吡咯烷酮无定形分散体制备中的比较。
Mol Pharm. 2011 Apr 4;8(2):532-42. doi: 10.1021/mp1003674. Epub 2011 Mar 3.
6
Influence of humidity on the phase behavior of API/polymer formulations.湿度对活性药物成分/聚合物制剂相行为的影响。
Eur J Pharm Biopharm. 2015 Aug;94:352-62. doi: 10.1016/j.ejpb.2015.06.009. Epub 2015 Jun 24.
7
Physical stability of API/polymer-blend amorphous solid dispersions.原料药/聚合物共混无定形固体分散体的物理稳定性。
Eur J Pharm Biopharm. 2018 Mar;124:147-157. doi: 10.1016/j.ejpb.2017.12.002. Epub 2017 Dec 18.
8
Dissolution and precipitation behavior of amorphous solid dispersions.无定形固体分散体的溶解和沉淀行为。
J Pharm Sci. 2011 Aug;100(8):3316-3331. doi: 10.1002/jps.22579. Epub 2011 May 23.
9
Influence of Low-Molecular-Weight Excipients on the Phase Behavior of PVPVA64 Amorphous Solid Dispersions.低分子量辅料对 PVPVA64 无定形固体分散体相行为的影响。
Pharm Res. 2018 Jan 5;35(1):25. doi: 10.1007/s11095-017-2316-y.
10
Effect of preparation method on the surface properties and UV imaging of indomethacin solid dispersions.制备方法对吲哚美辛固体分散体表面性质和紫外成像的影响。
Eur J Pharm Biopharm. 2019 Apr;137:148-163. doi: 10.1016/j.ejpb.2019.03.002. Epub 2019 Mar 2.

引用本文的文献

1
Predicting the Release Mechanism of Amorphous Solid Dispersions: A Combination of Thermodynamic Modeling and In Silico Molecular Simulation.预测无定形固体分散体的释放机制:热力学建模与计算机分子模拟相结合
Pharmaceutics. 2024 Oct 2;16(10):1292. doi: 10.3390/pharmaceutics16101292.
2
Development, Characterization, and Cellular Toxicity Evaluation of Solid Dispersion-Loaded Hydrogel Based on Indomethacin.基于吲哚美辛的固体分散体负载水凝胶的制备、表征及细胞毒性评价
Polymers (Basel). 2024 Jul 30;16(15):2174. doi: 10.3390/polym16152174.
3
Thermodynamic Modeling of the Amorphous Solid Dispersion-Water Interfacial Layer and Its Impact on the Release Mechanism.

本文引用的文献

1
Thermodynamic phase behaviour of indomethacin/PLGA formulations.吲哚美辛/聚乳酸-羟基乙酸共聚物制剂的热力学相行为
Eur J Pharm Biopharm. 2015 Jun;93:88-94. doi: 10.1016/j.ejpb.2015.01.029. Epub 2015 Mar 16.
2
Influence of copolymer composition on the phase behavior of solid dispersions.共聚物组成对固体分散体相行为的影响。
Mol Pharm. 2014 Nov 3;11(11):4189-98. doi: 10.1021/mp500412d. Epub 2014 Oct 21.
3
Thermodynamic phase behavior of API/polymer solid dispersions.活性药物成分/聚合物固体分散体的热力学相行为
非晶态固体分散体 - 水界面层的热力学建模及其对释放机制的影响。
Pharmaceutics. 2023 May 19;15(5):1539. doi: 10.3390/pharmaceutics15051539.
4
Liposomal Formulation for Oral Delivery of Cyclosporine A: Usefulness as a Semisolid-Dispersion System.环孢素 A 的口服递药脂质体制剂:作为半固体分散体系的实用性。
Pharm Res. 2022 May;39(5):977-987. doi: 10.1007/s11095-022-03276-0. Epub 2022 May 2.
5
Determination of Inherent Dissolution Performance of Drug Substances.药物物质固有溶出性能的测定。
Pharmaceutics. 2021 Jan 22;13(2):146. doi: 10.3390/pharmaceutics13020146.
6
The interplay of dissolution, solution crystallization and solid-state transformation of amorphous indomethacin in aqueous solution.非晶态吲哚美辛在水溶液中的溶解、溶液结晶及固态转变的相互作用。
Int J Pharm X. 2020 Nov 28;2:100063. doi: 10.1016/j.ijpx.2020.100063. eCollection 2020 Dec.
7
Developing HME-Based Drug Products Using Emerging Science: a Fast-Track Roadmap from Concept to Clinical Batch.利用新兴科学开发基于 HME 的药物产品:从概念到临床批次的快速通道路线图。
AAPS PharmSciTech. 2020 Jun 22;21(5):176. doi: 10.1208/s12249-020-01713-0.
8
Amorphous-Amorphous Phase Separation in API/Polymer Formulations.药物活性成分/聚合物制剂中的非晶态-非晶态相分离
Molecules. 2017 Feb 15;22(2):296. doi: 10.3390/molecules22020296.
Mol Pharm. 2014 Jul 7;11(7):2294-304. doi: 10.1021/mp400729x. Epub 2014 May 28.
4
Dissolution testing of amorphous solid dispersions.无定形固体分散体的溶出度测试。
Int J Pharm. 2013 Feb 28;444(1-2):40-6. doi: 10.1016/j.ijpharm.2013.01.042. Epub 2013 Jan 28.
5
Osmotic coefficients of aqueous weak electrolyte solutions: influence of dissociation on data reduction and modeling.水溶液中弱电解质的渗透系数:离解对数据简化和建模的影响。
J Phys Chem B. 2012 Jun 28;116(25):7479-91. doi: 10.1021/jp3005629. Epub 2012 Jun 18.
6
Mechanistic insights into the dissolution of spray-dried amorphous solid dispersions.喷雾干燥无定形固体分散体溶解的机制研究。
J Pharm Sci. 2012 Aug;101(8):2798-810. doi: 10.1002/jps.23192. Epub 2012 May 16.
7
Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels.聚(2-羟乙基甲基丙烯酸酯)水凝胶中吲哚美辛无定形固体分散体的增强动力学溶解度谱。
Eur J Pharm Biopharm. 2012 May;81(1):149-58. doi: 10.1016/j.ejpb.2011.12.016. Epub 2012 Jan 2.
8
Assessing the performance of amorphous solid dispersions.评估无定形固体分散体的性能。
J Pharm Sci. 2012 Apr;101(4):1355-77. doi: 10.1002/jps.23031. Epub 2011 Dec 27.
9
Dissolution and precipitation behavior of amorphous solid dispersions.无定形固体分散体的溶解和沉淀行为。
J Pharm Sci. 2011 Aug;100(8):3316-3331. doi: 10.1002/jps.22579. Epub 2011 May 23.
10
Understanding the behavior of amorphous pharmaceutical systems during dissolution.理解非晶态药物系统在溶解过程中的行为。
Pharm Res. 2010 Apr;27(4):608-18. doi: 10.1007/s11095-009-0021-1. Epub 2010 Feb 12.